BridgeBio Pharma Inc (BBIO) — Net Asset Quality Index
BridgeBio Pharma Inc (BBIO) has a Net Asset Quality Index of -192.6% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $998.25 Million minus total liabilities of $2.92 Billion yields net assets of $-1.92 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check asset resilience ratio of BridgeBio Pharma Inc to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
BridgeBio Pharma Inc Net Asset Quality Index Over Time (2017–2024)
This chart shows how BridgeBio Pharma Inc's Net Asset Quality Index has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the index stands at -192.6%, representing net assets of $-1.92 Billion against total assets of $998.25 Million USD. See how liquid is BridgeBio Pharma Inc's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for BridgeBio Pharma Inc (2017–2024)
The table below presents the year-by-year Net Asset Quality Index for BridgeBio Pharma Inc from 2017 to 2024, covering 8 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see BBIO market cap overview.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | -158.6% | $-1.46 Billion | $919.34 Million | $2.38 Billion | ▲ +87.2 pp |
| 2023 | -245.7% | $-1.34 Billion | $546.38 Million | $1.89 Billion | ▼ -45.9 pp |
| 2022 | -199.8% | $-1.24 Billion | $623.04 Million | $1.87 Billion | ▼ -114.4 pp |
| 2021 | -85.5% | $-865.58 Million | $1.01 Billion | $1.88 Billion | ▼ -100.8 pp |
| 2020 | 15.3% | $107.89 Million | $703.59 Million | $595.70 Million | ▼ -60.0 pp |
| 2019 | 75.4% | $475.98 Million | $631.68 Million | $155.70 Million | ▲ +97.2 pp |
| 2018 | -21.8% | $-101.50 Million | $464.94 Million | $566.44 Million | ▲ +33.9 pp |
| 2017 | -55.8% | $-54.69 Million | $98.04 Million | $152.73 Million | — |